Emergent BioSolutions Inc - Company Profile
Powered by 
All the data and insights you need on Emergent BioSolutions Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Emergent BioSolutions Inc Strategy Report
- Understand Emergent BioSolutions Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Emergent BioSolutions Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| WO2022187361A1 | Application | VALIOLAMINE DERIVATIVES AS GLUCOSIDASE INHIBITORS | September 09, 2022 | |
| EP4048306A1 | Application | CHIKUNGUNYA-VIRUS-ÄHNLICHER PARTIKELIMPFSTOFF UND VERFAHREN ZU SEINER VERWENDUNG | A61K2039/5258; A61K2039/545; A61K2039/55505; A61K39/12; A61P31/12; A61P31/14; C07K14/005; C12N2770/36123; C12N2770/36134; C12N2770/36171; Y02A50/30 | August 31, 2022 |
| WO2022177990A2 | Application | MODIFIED SARS-COV-2 SPIKE POLYPEPTIDES AND NANOPARTICLES THEREOF | August 25, 2022 | |
| USD0957624S | Grant | Autoinjector | July 12, 2022 | |
| KR1020220097422A | Application | 치쿤구니야 바이러스 유사 입자 백신 및 이의 사용 방법 | A61K2039/5258; A61K2039/545; A61K2039/55505; A61K39/12; A61P31/12; A61P31/14; C07K14/005; C12N2770/36123; C12N2770/36134; C12N2770/36171; Y02A50/30 | July 07, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward